Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 4/20 | 0.46 |
| ▸ | CSNK2A1 | P68400 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HRH1 | P35367 | 1/20 | 0.45 |
| ▸ | CCR3 | P51677 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.43 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6132526 | 0.99 | CSNK2A2 (0.45) | CSNK2A2CSNK2A1TSHRHRH1CCR3 | |
| SCHEMBL6241221 | 0.87 | USP2 (0.46) | TSHRUSP2ALDH1A1PDE4DPDE7A | |
| SCHEMBL6232666 | 0.87 | USP2 (0.55) | TSHRHRH1CCR3KCNH2USP2 | |
| SCHEMBL6132282 | 0.86 | PDE4D (0.46) | TSHRUSP2ALDH1A1PDE4DPDE7A | |
| SCHEMBL6135547 | 0.83 | HRH3 (0.52) | CSNK2A2CSNK2A1USP2CSNK2BCHEK1 | |
| SCHEMBL6134222 | 0.82 | HRH3 (0.53) | CSNK2A2CSNK2A1USP2CSNK2BCHEK1 | |
| SCHEMBL6134406 | 0.82 | HRH3 (0.53) | CSNK2A2CSNK2A1USP2CSNK2BCHEK1 | |
| SCHEMBL6134912 | 0.81 | USP2 (0.43) | CSNK2A2CSNK2A1HRH1CCR3KCNH2 | |
| SCHEMBL7340640 | 0.81 | CSNK2A2 (0.54) | CSNK2A2CSNK2A1TSHRUSP2ALDH1A1 | |
| SCHEMBL6236412 | 0.79 | HDAC3 (0.45) | TSHRUSP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005005463-A1 | ANTIFUNGAL CYCLIC LIPOPEPTIDES | ASTELLAS PHARMA INC. (JP) | 2005-01-20 | — | — | WO | disclosed |
| US-20050014685-A1 | New compound | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014685-A1 | New compound | MAN2B1, MAN2A1, MANBA | CSNK2A2 2712/4885CSNK2A1 2134/4885TSHR 3529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.